Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 196 AL 210

Effects of Dihuang Yinzi Decoction on Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhang Z, Zhu Y, Zhu C, Li S, Zhao Y, Yang J, Qin Y, Hou J, Zhang J, Han C.

Complement Med Res. 2023;30(5):440-452. doi: 10.1159/000531931. Epub 2023 Aug 11.

The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review

Pang LW, Hamzah S, Tan SLJ, Mah SH, Yow HY.

Neurochem Res. 2023 Dec;48(12):3485-3511. doi: 10.1007/s11064-023-04005-8. Epub 2023 Aug 14.

Acoustic stimulation as a promising technique to enhance slow-wave sleep in Alzheimer's disease: results of a pilot study

Van den Bulcke L, Peeters AM, Heremans E, Davidoff H, Borzée P, De Vos M, Emsell L, Van den Stock J, De Roo M, Tournoy J, Buyse B, Vandenbulcke M, Van Audenhove C, Testelmans D, Van Den Bossche M.

J Clin Sleep Med. 2023 Dec 1;19(12):2107-2112. doi: 10.5664/jcsm.10778.

Where are caregivers in the clinical trial? Evaluation of caregiver responsibilities in Alzheimer's disease and related dementias clinical trials

Miranda A, Rubovits E, Mudar R, Leung V, Raj M.

Alzheimers Dement. 2023 Nov;19(11):5316-5322. doi: 10.1002/alz.13418. Epub 2023 Aug 18.

The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3 × Tg-AD) mouse model strain

Tian S, Ye T, Cheng X.

Exp Neurol. 2023 Oct;368:114505. doi: 10.1016/j.expneurol.2023.114505. Epub 2023 Aug 18.

New treatments for Alzheimer's disease

Howard R, Kales HC.

BMJ. 2023 Aug 22;382:1852. doi: 10.1136/bmj.p1852.

Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease

Aili M, Zhou K, Zhan J, Zheng H, Luo F.

J Mater Chem B. 2023 Sep 20;11(36):8605-8621. doi: 10.1039/d3tb01023f.

Feasibility of Telehealth Occupational Therapy for Behavioral Symptoms of Adults With Dementia: Randomized Controlled Trial

Rhodus EK, Baum C, Kryscio R, Liu C, George R, Thompson M, Lowry K, Coy B, Barber J, Nichols H, Curtis A, Holloman A, Jicha GA.

Am J Occup Ther. 2023 Jul 1;77(4):7704205010. doi: 10.5014/ajot.2023.050124.

A New Perspective for the Treatment of Alzheimer's Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies

Ribeiro J, Lopes I, Gomes AC.

Molecules. 2023 Aug 11;28(16):6015. doi: 10.3390/molecules28166015.

Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease

Pati S, Singh Gautam A, Dey M, Tiwari A, Kumar Singh R.

Drug Discov Today. 2023 Dec;28(12):103750. doi: 10.1016/j.drudis.2023.103750. Epub 2023 Aug 24.

Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test

Costa T, Premi E, Liloia D, Cauda F, Manuello J.

J Alzheimers Dis. 2023;95(3):1059-1065. doi: 10.3233/JAD-230589.

Management of neuropsychiatric symptoms in dementia

Devanand DP.

Curr Opin Neurol. 2023 Oct 1;36(5):498-503. doi: 10.1097/WCO.0000000000001199. Epub 2023 Aug 7.

Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain

Edland SD, Llibre-Guerra JJ.

Neurology. 2023 Oct 3;101(14):593-594. doi: 10.1212/WNL.0000000000207861. Epub 2023 Aug 29.

Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological properties

Liu J, Li T, Zhong G, Pan Y, Gao M, Su S, Liang Y, Ma C, Liu Y, Wang Q, Shi Q.

Biomed Pharmacother. 2023 Oct;166:115406. doi: 10.1016/j.biopha.2023.115406. Epub 2023 Sep 4.

Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases

Alam M, Ahmed S, Abid M, Hasan GM, Islam A, Hassan MI.

J Cell Biochem. 2023 Sep;124(9):1223-1240. doi: 10.1002/jcb.30468. Epub 2023 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias